An Experiment To Find The Effect Of Punarnava Astaka Kwatha Ghanvati For The Treatment Of Liver disease

A Pilot Study To Evaluate The Efficacy Of Punarnava Astaka Kwatha Ghanvati In Management Of Liver Cirrhosis - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/068005

Enrollment

Registered

2024-05-28

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K746- Other and unspecified cirrhosis ofliver

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients meeting the specified diagnostic criteria will be included in the study. 2. Class A, class B category of CHILD PUGH SCORE patient will be included in study.

Exclusion criteria

Exclusion criteria: 1. Patients group of age below 18 and above 70. 2. Pregnant or Lactating Females. 3. Patients suffering from malignancy, tuberculosis, leprosy, Liver cyst, etc. 4. Patients Suffering from HIV+ve

Design outcomes

Primary

Measure	Time frame
To Reduce CHILD PUGH score ( Ascites, Albumin, PT INR, Total Billirubin, Hepatic Encephalopathy) of liver cirrhosisTimepoint: 4 Months Medicine With 2 Month Followup	—

Secondary

Measure	Time frame
To Reduce Symptom Of Loss Of Appetite, Nausea And Vomiting, Discomfort In The Right Upper Quadrant Of The Abdomen, Swelling In The Lower Limbs, Weakness, Jaundice, Abdominal Heaviness.Timepoint: 4 Months Medicine With 2 Month Followup	—

Countries

India

Contacts

Public ContactDr Hemant Toshikhane

Parul Institute Of Ayurved

hemant.toshikhane@paruluniversity.ac.in8469496525

Outcome results